GRANIX
NDC 63459-918, tbo-filgrastim, injection, solution, from Cephalon, LLC.
- Product NDC
- 63459-918
- Status
- Listed
- Labeler
- Cephalon, LLC
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA125294
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63459-918 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FILGRASTIM300 ug/mL
Pharmacologic classes
Granulocyte Colony-Stimulating Factor [CS]; Increased Myeloid Cell Production [PE]; Leukocyte Growth Factor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63459-918-59 | 63459091859 | 10 VIAL in 1 CARTON (63459-918-59) / 1 mL in 1 VIAL (63459-918-53) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/df918ec2-0907-443f-a52a-b72866959644Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=63459-918
Use it
Look up 63459-918 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63459-918 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63459-918. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.